Plasma lipoprotein distribution of liposomal nystatin is influenced by protein content of high-density lipoproteins

The plasma lipoprotein distribution of free nystatin (Nys) and liposomal nystatin (L-Nys) in human plasma samples with various lipoprotein lipid and protein concentrations and compositions was investigated. To assess the lipoprotein distributions of Nys and L-Nys, human plasma was incubated with Nys and L-Nys (equivalent to 20 microg/ml) for 5 min at 37 degreesC. The plasma was subsequently partitioned into its lipoprotein and lipoprotein-deficient plasma fractions by step-gradient ultracentrifugation, and each fraction was analyzed for Nys content by high-pressure liquid chromatography. The lipid and protein contents and compositions of each fraction were determined with enzymatic kits. Following the incubation of Nys and L-Nys in human plasma the majority of Nys recovered within the lipoprotein fractions was recovered from the high-density lipoprotein (HDL) fraction. Incorporation of Nys into liposomes consisting of dimyristoylphosphatidylcholine and dimyristoylphosphatidylglycerol significantly increased the percentage of drug recovered within the HDL fraction. Furthermore, it was observed that as the amount of HDL protein decreased the amounts of Nys and L-Nys recovered within this fraction decreased. These findings suggest that the preferential distribution of Nys and L-Nys into plasma HDL may be a function of the HDL protein concentration.     

Regulation of CYP3A9 gene expression by estrogen and catalytic studies using cytochrome P450 3A9 expressed in Escherichia coli

BACKGROUND: In patients with reflux oesophagitis, endoscopic healing and symptom relief are considered important treatment goals in long-term care. AIM: To compare the effect of lansoprazole 15 and 30 mg daily on maintaining endoscopic healing and symptom relief in patients with moderate reflux oesophagitis. PATIENTS AND METHODS: In a single-centre, double-blind randomized clinical trial, 103 patients with grade 1 or 2 reflux oesophagitis who were endoscopically healed and asymptomatic after lansoprazole 30 mg daily for 12 weeks, were randomized to maintenance therapy with either lansoprazole 15 mg or 30 mg o.m. Endoscopy was repeated after 3, 6 and 12 months, and symptom relief assessed after 3, 6, 9 and 12 months. Relapse of oesophagitis or symptoms were considered end-points. RESULTS: After 12 months, 14/50 patients (28%) receiving lansoprazole 15 mg daily had suffered an endoscopic relapse compared to 8/53 patients (15%) treated with lansoprazole 30 mg daily. A life table analysis showed no statistically significant difference between the two groups (P = 0.086). Significantly more patients were kept in complete symptomatic remission in the 30 mg group (P < 0.01). In the 15 mg group, 23/50 (46%) had suffered either an endoscopic or symptomatic relapse on completion of the study, compared to 12/53 (23%) in the 30 mg group. A life table analysis showed this difference to be statistically significant (P = 0.010). Lansoprazole 15 and 30 mg daily were equally well tolerated. CONCLUSION: No statistically significant differences were found in endoscopic relapse rate or occurrence of adverse events, while lansoprazole 30 mg proved superior to 15 mg in maintaining patients in symptomatic relief and combined endoscopic and symptomatic remission.     

Observation and analysis of magnetostatic modes in K2CuF4

By means of ferromagnetic resonance experiments, we have observed magnetostatic modes in the quasi-two-dimensional transparent ferromagnet K₂CuF₄. In spite of the problems with the shape of the sample resulting from layer structure properties of K₂CuF₄, we have been able to analyse the magnetostatic modes in terms of a normally magnetised disk.     

Entwicklung einer niedrigschmelzenden Legierung und deren Applikation zum Korrosionsschutz hochfester Stähle

Development of low‐temperature galvanizing and its application for corrosion protection of high‐strength steels Apart from reliability and quality, vehicle safety and cost efficiency are the decisive criteria for automobile manufacturers. Corrosion protection plays a decisive role because it increases the service life. The ultra‐high‐strength steels are materials which exhibit high lightweight potential as well as a very good energy absorption capacity because of their mechanical properties. In connection with the possibility of hot forming, they are predestined for the fabrication of complicated, load‐compatible shapes in the crash‐relevant frame and body construction. The application of these steel qualities has been carried out in structural parts which are protected from corrosion by a hot‐dip coat of FeAl7 – the so‐called Usibor. However, at the moment there is no ready‐for‐production solution for later corrosion protection of already hot‐formed parts. Therefore, a corrosion protection system on the basis of conventional low‐temperature galvanizing processes has been developed and utilized. First, the softening behavior of the highly‐resistant 22MnB5 substrate was analyzed. Afterwards, a galvanizing system was developed and applied. The corrosion protection coatings were characterized with regard to their structure and corrosion protection potential. As a result, a significant improvement of the corrosion behaviour has occurred.     

A minor groove RNA triple helix within the catalytic core of a group I intron

Close packing of several double helical and single stranded RNA elements is required for the Tetrahymena group I ribozyme to achieve catalysis. The chemical basis of these packing interactions is largely unknown. Using nucleotide analog interference suppression (NAIS), we demonstrate that the P1 substrate helix and J8/7 single stranded segment form an extended minor groove triple helix within the catalytic core of the ribozyme. Because each triple in the complex is mediated by at least one 2'-OH group, this substrate recognition triplex is unique to RNA and is fundamentally different from major groove homopurine-homopyrimidine triplexes. We have incorporated these biochemical data into a structural model of the ribozyme core that explains how the J8/7 strand organizes several helices within this complex RNA tertiary structure.